On 2025-05-08, Turnstone Biologics Corp. (TSBX) announced earnings per share of $-0.51 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.26.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.16 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.26 | $-0.51 |
| 2025-03-28 | 2024-12-31 | $-0.69 | $-0.56 |
| 2024-11-12 | 2024-09-30 | $-0.87 | $-0.74 |
| 2024-08-14 | 2024-06-30 | $-0.84 | $-0.92 |
| 2024-05-13 | 2024-03-31 | $-0.78 | $-0.85 |
| 2024-03-21 | 2023-12-31 | $-0.86 | $-0.73 |
| 2023-11-09 | 2023-09-30 | $-0.67 | $-1.00 |
| 2023-09-01 | 2023-06-30 | -- | $-7.56 |